HOVON 181 AML: A study to investigate the effect of adding bleximenib to standard-of-care treatment with intensive chemotherapy in patients with a specific type of acute myeloid leukemia (AML).

bleximenib (JNJ-6617) - J&J, Blackstone Health

Feb 18, 2026